Targeted O -glycoproteomics explored increased sialylation and identified MUC16 as a poor prognosis biomarker in advanced-stage bladder tumours
出版年份 2017 全文链接
标题
Targeted O
-glycoproteomics explored increased sialylation and identified MUC16 as a poor prognosis biomarker in advanced-stage bladder tumours
作者
关键词
-
出版物
Molecular Oncology
Volume 11, Issue 8, Pages 895-912
出版商
Wiley
发表日期
2017-02-03
DOI
10.1002/1878-0261.12035
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends
- (2017) Sebastien Antoni et al. EUROPEAN UROLOGY
- EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016
- (2017) Marko Babjuk et al. EUROPEAN UROLOGY
- Perspectives on Anti-Glycan Antibodies Gleaned from Development of a Community Resource Database
- (2016) Eric Sterner et al. ACS Chemical Biology
- N-acetylgalactosamine glycans function in cancer cell adhesion to endothelial cells: A role for truncated O-glycans in metastatic mechanisms
- (2016) Deepashree Bapu et al. CANCER LETTERS
- Mechanisms of cisplatin resistance and targeting of cancer stem cells: Adding glycosylation to the equation
- (2016) José Alexandre Ferreira et al. DRUG RESISTANCE UPDATES
- Glycosylation and other PTMs alterations in neurodegenerative diseases: Current status and future role in neurotrauma
- (2016) Hussein Abou-Abbass et al. ELECTROPHORESIS
- Hypoxia enhances the malignant nature of bladder cancer cells and concomitantly antagonizes protein O-glycosylation extension
- (2016) Andreia Peixoto et al. Oncotarget
- The Sweet Side of Immune Evasion: Role of Glycans in the Mechanisms of Cancer Progression
- (2016) Ana Flávia Fernandes Ribas Nardy et al. Frontiers in Oncology
- Glycans in the immune system and The Altered Glycan Theory of Autoimmunity: A critical review
- (2015) Emanual Maverakis et al. JOURNAL OF AUTOIMMUNITY
- Emerging antibody-based therapeutic strategies for bladder cancer: A systematic review
- (2015) Rita Azevedo et al. JOURNAL OF CONTROLLED RELEASE
- New trends in guided nanotherapies for digestive cancers: A systematic review
- (2015) Elisabete Fernandes et al. JOURNAL OF CONTROLLED RELEASE
- Probing the O-Glycoproteome of Gastric Cancer Cell Lines for Biomarker Discovery
- (2015) Diana Campos et al. MOLECULAR & CELLULAR PROTEOMICS
- PANTHER version 10: expanded protein families and functions, and analysis tools
- (2015) Huaiyu Mi et al. NUCLEIC ACIDS RESEARCH
- Bladder Tumor Heterogeneity: The Impact on Clinical Treatment
- (2015) Chao Chen et al. UROLOGIA INTERNATIONALIS
- Expression of the Carboxy-Terminal Portion of MUC16/CA125 Induces Transformation and Tumor Invasion
- (2015) Thapi D. Rao et al. PLoS One
- Abnormal Protein Glycosylation and Activated PI3K/Akt/mTOR Pathway: Role in Bladder Cancer Prognosis and Targeted Therapeutics
- (2015) Céu Costa et al. PLoS One
- MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress
- (2014) Mildred Felder et al. Molecular Cancer
- Detection of glyco-mucin profiles improves specificity of MUC16 and MUC1 biomarkers in ovarian serous tumours
- (2014) Sara Ricardo et al. Molecular Oncology
- Sialyl Tn-expressing bladder cancer cells induce a tolerogenic phenotype in innate and adaptive immune cells
- (2014) Mylène A. Carrascal et al. Molecular Oncology
- P53 and Cancer-Associated Sialylated Glycans Are Surrogate Markers of Cancerization of the Bladder Associated with Schistosoma haematobium Infection
- (2014) Júlio Santos et al. PLoS Neglected Tropical Diseases
- Response of high-risk of recurrence/progression bladder tumours expressing sialyl-Tn and sialyl-6-T to BCG immunotherapy
- (2013) L Lima et al. BRITISH JOURNAL OF CANCER
- Precision mapping of the human O-GalNAc glycoproteome through SimpleCell technology
- (2013) Catharina Steentoft et al. EMBO JOURNAL
- Overexpression of tumour-ssociated carbohydrate antigen sialyl-Tn in advanced bladder tumours
- (2013) José Alexandre Ferreira et al. Molecular Oncology
- FASL polymorphism is associated with response to bacillus Calmette-Guérin immunotherapy in bladder cancer
- (2013) Luís Lima et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Epidemiology and Risk Factors of Urothelial Bladder Cancer
- (2012) Maximilian Burger et al. EUROPEAN UROLOGY
- Vertebrate protein glycosylation: diversity, synthesis and function
- (2012) Kelley W. Moremen et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Synthesis and Optimization of Lectin Functionalized Nanoprobes for the Selective Recovery of Glycoproteins from Human Body Fluids
- (2011) José A. Ferreira et al. ANALYTICAL CHEMISTRY
- Bladder Cancer and Cancer Stem Cells: Basic Science and Implications for Therapy
- (2011) Richard T. Bryan TheScientificWorldJOURNAL
- The prognostic and predictive value of CA-125 regression during neoadjuvant chemotherapy for advanced ovarian or primary peritoneal carcinoma
- (2010) Naveen S. Vasudev et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- Human dendritic cells contain cell surface sialyltransferase activity
- (2010) M. Guadalupe Cabral et al. IMMUNOLOGY LETTERS
- ST3Gal.I sialyltransferase relevance in bladder cancer tissues and cell lines
- (2009) Paula A Videira et al. BMC CANCER
- Lack of pathologic down-staging with neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma of the bladder
- (2009) Christopher J. Weight et al. CANCER
- Elevated Golgi pH impairs terminalN-glycosylation by inducing mislocalization of Golgi glycosyltransferases
- (2009) Antti Rivinoja et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Inactivating germ-line and somatic mutations in polypeptide N-acetylgalactosaminyltransferase 12 in human colon cancers
- (2009) K. Guda et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The present and future burden of urinary bladder cancer in the world
- (2009) Martine Ploeg et al. WORLD JOURNAL OF UROLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started